Feasibility of serum CGRP measurement as a biomarker of chronic migraine: a critical reappraisal
Abstract Background Calcitonin gene-related peptide (CGRP) has been reported as elevated in chronic migraine. We aimed to validate the role of interictal serum CGRP concentration in peripheral blood samples as a biomarker of chronic migraine. Methods We prospectively recruited patients with episodic...
Main Authors: | Mi Ji Lee, Sook-Yeon Lee, Soohyun Cho, Eun-Suk Kang, Chin-Sang Chung |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-07-01
|
Series: | The Journal of Headache and Pain |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s10194-018-0883-x |
Similar Items
-
CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?
by: Valentina Favoni, et al.
Published: (2019-03-01) -
Prevention of migraine with monoclonal antibodies against CGRP or the CGRP receptor
by: Hans-Christoph Diener, et al.
Published: (2020-04-01) -
New Trends in Migraine Pharmacology: Targeting Calcitonin Gene–Related Peptide (CGRP) With Monoclonal Antibodies
by: Damiana Scuteri, et al.
Published: (2019-04-01) -
Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy
by: Damiana Scuteri, et al.
Published: (2021-07-01) -
Plasma levels of CGRP and expression of specific microRNAs in blood cells of episodic and chronic migraine subjects: towards the identification of a panel of peripheral biomarkers of migraine?
by: Rosaria Greco, et al.
Published: (2020-10-01)